BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 24477081)

  • 1. Does recombinant human bone morphogenetic protein-2 use in adult spinal deformity increase complications and are complications associated with location of rhBMP-2 use? A prospective, multicenter study of 279 consecutive patients.
    Bess S; Line BG; Lafage V; Schwab F; Shaffrey CI; Hart RA; Boachie-Adjei O; Akbarnia BA; Ames CP; Burton DC; Deverin V; Fu KM; Gupta M; Hostin R; Kebaish K; Klineberg E; Mundis G; O'Brien M; Shelokov A; Smith JS;
    Spine (Phila Pa 1976); 2014 Feb; 39(3):233-42. PubMed ID: 24477081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
    Lykissas MG; Aichmair A; Sama AA; Hughes AP; Lebl DR; Cammisa FP; Girardi FP
    Spine J; 2014 Feb; 14(2):217-24. PubMed ID: 24269858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 2: BMP dosage-related complications and long-term outcomes in 509 patients.
    Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
    Spine (Phila Pa 1976); 2013 Jun; 38(13):1137-45. PubMed ID: 23354111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications of rhBMP-2 utilization for posterolateral lumbar fusions requiring reoperation: a single practice, retrospective case series report.
    Hoffmann MF; Jones CB; Sietsema DL
    Spine J; 2013 Oct; 13(10):1244-52. PubMed ID: 23973099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 1: Large series diagnosis related outcomes and complications with 2- to 9-year follow-up.
    Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
    Spine (Phila Pa 1976); 2013 Jun; 38(13):1128-36. PubMed ID: 23370679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
    Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
    Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long adult spinal deformity fusion to the sacrum using rhBMP-2 versus autogenous iliac crest bone graft.
    Maeda T; Buchowski JM; Kim YJ; Mishiro T; Bridwell KH
    Spine (Phila Pa 1976); 2009 Sep; 34(20):2205-12. PubMed ID: 19752707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
    Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
    Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions.
    Adams CL; Ogden K; Robertson IK; Broadhurst S; Edis D
    Spine (Phila Pa 1976); 2014 Jan; 39(2):164-71. PubMed ID: 24153173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion.
    Singh K; Nandyala SV; Marquez-Lara A; Cha TD; Khan SN; Fineberg SJ; Pelton MA
    Spine J; 2013 Sep; 13(9):1118-25. PubMed ID: 24029138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications with recombinant human bone morphogenetic protein-2 in posterolateral spine fusion associated with a dural tear.
    Glassman SD; Gum JL; Crawford CH; Shields CB; Carreon LY
    Spine J; 2011 Jun; 11(6):522-6. PubMed ID: 20598649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose rhBMP-2 for adults: major and minor complications: a study of 502 spine cases.
    Mesfin A; Buchowski JM; Zebala LP; Bakhsh WR; Aronson AB; Fogelson JL; Hershman S; Kim HJ; Ahmad A; Bridwell KH
    J Bone Joint Surg Am; 2013 Sep; 95(17):1546-53. PubMed ID: 24005194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study.
    Comer GC; Smith MW; Hurwitz EL; Mitsunaga KA; Kessler R; Carragee EJ
    Spine J; 2012 Oct; 12(10):881-90. PubMed ID: 23098617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions.
    Vaidya R; Sethi A; Bartol S; Jacobson M; Coe C; Craig JG
    J Spinal Disord Tech; 2008 Dec; 21(8):557-62. PubMed ID: 19057248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose Adjustment Associated Complications of Bone Morphogenetic Protein: A Longitudinal Assessment.
    De Stefano FA; Elarjani T; Burks JD; Burks SS; Levi AD
    World Neurosurg; 2021 Dec; 156():e64-e71. PubMed ID: 34530148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revision surgery after interbody fusion with rhBMP-2: a cautionary tale for spine surgeons.
    Rodgers SD; Marascalchi BJ; Grobelny BT; Smith ML; Samadani U
    J Neurosurg Spine; 2013 Jun; 18(6):582-7. PubMed ID: 23560709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RhBMP-2 is superior to iliac crest bone graft for long fusions to the sacrum in adult spinal deformity: 4- to 14-year follow-up.
    Kim HJ; Buchowski JM; Zebala LP; Dickson DD; Koester L; Bridwell KH
    Spine (Phila Pa 1976); 2013 Jun; 38(14):1209-15. PubMed ID: 23392417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of rhBMP-2 for adult spinal deformity surgery: patterns of usage and changes over the past decade.
    Bannwarth M; Smith JS; Bess S; Klineberg EO; Ames CP; Mundis GM; Kim HJ; Lafage R; Gupta MC; Burton DC; Shaffrey CI; Schwab FJ; Lafage V;
    Neurosurg Focus; 2021 Jun; 50(6):E4. PubMed ID: 34062501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RhBMP-2-induced radiculitis in patients undergoing transforaminal lumbar interbody fusion: relationship to dose.
    Villavicencio AT; Burneikiene S
    Spine J; 2016 Oct; 16(10):1208-1213. PubMed ID: 27343729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2--but what is the cost?
    Mannion RJ; Nowitzke AM; Wood MJ
    Spine J; 2011 Jun; 11(6):527-33. PubMed ID: 20739225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.